Menu
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.

ProQR Therapeutics N.V. buy thomasw

Start price
€1.95
18.01.24 / 50%
Target price
-
18.01.25
Performance (%)
-14.44%
End price
€1.67
21.01.24
Summary
This prediction ended on 21.01.24 with a price of €1.67. The prediction for ProQR Therapeutics N.V. disappointed with a performance of -14.44%. thomasw has 50% into this prediction
Performance without dividends (%)
Name 1w 1m
ProQR Therapeutics N.V. -1.850% -1.850%
iShares Core DAX® 3.178% 0.980%
iShares Nasdaq 100 2.972% 0.925%
iShares Nikkei 225® 0.545% -4.556%
iShares S&P 500 2.367% 0.833%

According to thomasw what are the pros and cons of ProQR Therapeutics N.V. for the foreseeable future?

Pros
Could be worthwhile Investment >10% per year
Cons

Comments by thomasw for this prediction

In the thread ProQR Therapeutics N.V. diskutieren

Buy ProQR Therapeutics N.V.

In the thread Trading ProQR Therapeutics N.V.
Prediction Buy
Perf. (%) -14.44%
Target price
Change
Ends at 18.01.25

Buy beendet